A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Clinical trial NCT01545440 · COMPLETED
Trial details
- NCT number
- NCT01545440
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.